Universal Ibogaine Inc. (TSXV:IBO)
Canada flag Canada · Delayed Price · Currency is CAD
0.0050
-0.0050 (-50.00%)
At close: Feb 2, 2026

Universal Ibogaine Income Statement

Millions CAD. Fiscal year is Aug - Jul.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Apr '25 Jul '24 Jul '23 Jul '22 Jul '21 Jul '20
2.062.331.031.07--
Revenue Growth (YoY)
-11.68%126.32%-3.81%---
Cost of Revenue
1.71.781.060.57--
Gross Profit
0.360.55-0.030.5--
Selling, General & Admin
0.621.041.613.663.82.34
Research & Development
0.140.090.010.41-0.02
Amortization of Goodwill & Intangibles
-----0.98
Operating Expenses
1.061.452.025.243.863.37
Operating Income
-0.71-0.9-2.05-4.75-3.86-3.37
Interest Expense
-0.15-0.16-0.15-0.07-0.02-0.01
Currency Exchange Gain (Loss)
-----0.02-0.02
Other Non Operating Income (Expenses)
0.01--0.01-0.130.03-0.06
EBT Excluding Unusual Items
-0.85-1.06-2.22-4.94-3.87-3.45
Impairment of Goodwill
----1.46--
Gain (Loss) on Sale of Assets
-0.98-0.98-0.36---
Asset Writedown
0.36---1.24--2.15
Other Unusual Items
-0-0--2.85-0.03
Pretax Income
-1.48-2.05-2.39-10.5-3.87-5.57
Net Income
-1.48-2.05-2.39-10.5-3.87-5.57
Net Income to Common
-1.48-2.05-2.39-10.5-3.87-5.57
Shares Outstanding (Basic)
29723319118612534
Shares Outstanding (Diluted)
29723319118612534
Shares Change (YoY)
38.51%21.54%3.05%48.28%265.15%81.31%
EPS (Basic)
-0.00-0.01-0.01-0.06-0.03-0.16
EPS (Diluted)
-0.01-0.01-0.01-0.06-0.03-0.16
Free Cash Flow
-0.66-0.92-1.46-4.43-3.25-2.33
Free Cash Flow Per Share
-0.00-0.00-0.01-0.02-0.03-0.07
Gross Margin
17.31%23.67%-2.72%46.43%--
Operating Margin
-34.25%-38.66%-199.10%-443.24%--
Profit Margin
-71.66%-88.01%-232.08%-980.22%--
Free Cash Flow Margin
-32.20%-39.35%-141.50%-413.60%--
EBITDA
-0.36-0.56-1.75-4.48-3.8-2.36
EBITDA Margin
-17.39%-23.92%-170.36%---
D&A For EBITDA
0.350.340.30.270.071
EBIT
-0.71-0.9-2.05-4.75-3.86-3.37
EBIT Margin
-34.25%-38.66%-199.10%---
Advertising Expenses
-----0.31
Updated Apr 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.